Appointment of Pello Capital Ltd and Placing

RNS Number : 5113W
Alpha Growth PLC
19 August 2020
 

19th August 2020

 

 

Alpha Growth plc

(" Alpha ", or the "Company")

 

Appointment of Pello Capital Ltd and Placing

 

Alpha Growth plc (LSE:   ALGW), the financial services specialist in the growing longevity asset class, is pleased to announce the appointment of Pello Capital Limited ("Pello") as broker to the Company and the raising of £500,000 through a placing initiated and completed by Pello. The net proceeds of the placing will be predominantly used to fund development of the Alpha growth and income strategy and other general working capital purposes.

 

Placing

The gross proceeds of £500,000, was completed at a price of 1.40 pence which represents a discount of 17.6 per cent to the closing share price of 1.7 pence on 18th August 2020. The 35,714,286 Placing Shares being issued together represent approximately 17.4 per cent of the existing issued ordinary share capital of the Company immediately prior to the Placing.

 

Issue of Placing Shares

The payment and delivery of the Placing Shares is expected to take place on 7 September 2020 and is conditional on the Financial Conduct Authority approving a prospectus in accordance with the Prospectus Rules and the Placing Shares being admitted to listing on the Official List (standard listing segment) and to trading on the London Stock Exchange's main market for listed securities. The Placing Shares will have the same rights and benefits as, and rank pari passu in all respects with, the existing ordinary shares.

 

A further announcement will made in due course once the Prospectus has been published. 

 

Total Vo ti ng Rights

Following the issue of the Placing Shares, the Company's issued share capital will consist of 240,815,959 ordinary shares. Each share has one voting right and no shares are held in treasury; these figures may be used by shareholders in the Company as the denominator for the  calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Subscription facility

The prospectus also provides for a Subscription facility to give the Company the ability to issue up to 35,819,047 Ordinary Shares in the 12 months from the date of the prospectus without the requirement to issue a new prospectus , thus saving costs if required. The Subscription is not underwritten or otherwise guaranteed and there are no plans to utilize the facility at this time. Further information on the Subscription facility will be in the Prospectus.

 

Gobind Sahney, Executive Chairman of Alpha, commented:

"I and the Directors are pleased to be working with the team at Pello and very much appreciate their support of Alpha's business strategy. Their commitment to the Company and delivering exceptional service was clearly demonstrated through the swift completion of the Pello initiated placing. The growth and innovative vision of Dan Gee and his team for Pello is very impressive."

 

Daniel Gee, Managing Director of Pello, commented:

"We at Pello are delighted to have been able to support Gobind and his team at Alpha Growth with this placing. We look forward to building a longstanding relationship with the Company and continuing to assist in the exciting growth of the business."

 

 

** ENDS **

 

 

For more information, please visit www.algwplc.com   or contact the following :

 

Alpha Growth plc

+44 (0) 20 3959 8600

Gobind Sahney, Executive Chairman 

info@algwplc.com



Pello Capital Limited

+44 (0) 20 7710 9610

Mark Treharne

mt@pellocapital.com

 

 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

About Alpha Growth plc

Specialist in Longevity Assets

Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets. Building on its well-established network, the Alpha Growth Group has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The Group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide holistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

 

Longevity Assets and Non-correlation

As a longevity asset, it is non-correlated to the real estate, equity capital and commodity markets.  Its value is a function of time because as time passes the value gets closer to the face value of the policy. Hence creating a steady increase in the net asset value of the investment. This makes it highly attractive to investors wishing to counteract volatility within an investment portfolio and add yield.

 

Note: The Company only advises on and manages Longevity Assets that originate in the USA where the structured and life settlement market is highly regulated.

 

Forward Looking Statements Disclaimer

 

Certain statements, beliefs and opinions in this document are forward-looking, which reflect the Company's or, as appropriate, the Company's directors' current expectations and projections about future events. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in this document regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should not place undue reliance on forward- looking statements, which speak only as of the date of this document.  Readers should not treat the contents of this document as advice relating to legal, taxation or investment matters, and are to make their own assessments concerning these and other consequences, including the merits of information and the risks.  Readers of this announcement are advised to conduct their own due diligence and agree to be bound by the limitations of this disclaimer.

 

Important Notice

 

The content of this announcement has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000 (FSMA). This announcement has been issued by and is the sole responsibility of the Company. The information in this announcement is subject to change.

This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the Securities Act), and may not be offered or sold, directly or indirectly, in or into the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States. This announcement is not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, the Republic of South Africa, Japan or any jurisdiction where to do so might constitute a violation of local securities laws or regulations (a Prohibited Jurisdiction). This announcement and the information contained herein are not for release, publication or distribution, directly or indirectly, to persons in a Prohibited Jurisdiction unless permitted pursuant to an exemption under the relevant local law or regulation in any such jurisdiction.

Pello Capital Limited (Pello) is authorised and regulated by the Financial Conduct Authority in the United Kingdom. Pello is acting solely as the Company's broker and placing agent in relation to the Placing and for no one else in connection with the contents of this announcement and will not regard any other person (whether or not a recipient of this announcement) as its client in relation to the contents of this announcement nor will Pello be responsible to anyone other than the Company for providing the protections afforded to their clients or for providing advice in relation to the contents of this announcement. Apart from the responsibilities and liabilities, if any, which may be imposed on Pello by FSMA or the regulatory regime established thereunder, Pello accepts no responsibility whatsoever, and makes no representation or warranty, express or implied, for the contents of this announcement including its accuracy, completeness or verification or for any other statement made or purported to be made by it, or on behalf of it, the Company or any other person, in connection with the Company and the contents of this announcement, whether as to the past or the future.  Pello accordingly disclaims all and any liability whatsoever, whether arising in tort, contract or otherwise (save as referred to above), which it might otherwise have in respect of the contents of this announcement or any such statement.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEPPMMTMTBBTBM
UK 100

Latest directors dealings